Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Central/Eastern Europe, Middle East & Africa
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特區 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Paraguay
Perú (Peru)
Philippines
Polska (Poland)
Российская Федерация (Russia)
Portugal
Puerto Rico
Romania
العربية الشرق Middle East
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台灣地區 (Taiwan)
ประเทศไทย (Thailand)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Tiếng Việt (Vietnam)
TAVR VIDEOS & PRESENTATIONS
Heart valve treatment experts share insights on aortic stenosis, ACC/AHA Guidelines, TAVR, and more.
SPOTLIGHT ON AORTIC STENOSIS
Echo Best Practices - (02:37)
Experts share why it’s important to go beyond gradients when detecting the severity of aortic stenosis.
More information (see more)
Less information (see less)
Treatment Insights - (02:22)
Experts share their experiences assessing and treating patients with severe aortic stenosis.
More information (see more)
Less information (see less)
Importance of Echos - (01:31)
See why a proper echo is vital to diagnosing symptomatic severe aortic stenosis.
More information (see more)
Less information (see less)
Timely Referral - (01:40)
Learn about determining the severity of aortic stenosis and when to refer patients to the heart team.
More information (see more)
Less information (see less)
ACC/AHA GUIDELINES UPDATES & KEY CONSIDERATIONS
Guideline Overview - (04:14)
How the guidelines were developed and how they’ve changed from previous versions.
More information (see more)
Less information (see less)
Age Considerations - (06:15)
Thoughts on the guidelines and considerations for various patient age groups.
More information (see more)
Less information (see less)
Clinical Considerations - (04:55)
What to look at when determining a treatment approach for various types of patients.
More information (see more)
Less information (see less)
Guideline Awareness - (02:30)
How to get this guidance out to the heart surgeon and cardiologist communities who need it.
More information (see more)
Less information (see less)
STS Score Frailty - (02:54)
The use and importance of the STS score.
More information (see more)
Less information (see less)
Imaging Insights - (03:55)
What imaging and other techniques can reveal when identifying patients with symptomatic severe aortic stenosis.
More information (see more)
Less information (see less)
Accuracy of Imaging - (03:49)
The limitations and benefits of the different types of imaging.
More information (see more)
Less information (see less)
Future of Guidelines VHD - (02:44)
How the guidelines keep up with the changing understanding of heart valve disease.
More information (see more)
Less information (see less)
Shared Decision-Making - (05:44)
How the heart team can better engage and inform patients when considering a treatment approach.
More information (see more)
Less information (see less)
Valve Durability - (01:09)
The valve design attributes that lend themselves to better durability.
More information (see more)
Less information (see less)
ACC SHARED DECISION-MAKING SYMPOSIUM
TAVR AND THE LOW RISK POPULATION
Introduction: Pivoting to the Low Risk Population - (02:02)
Series overview and introduction to the heart valve patient expert panel.
More information (see more)
Less information (see less)
Clinical Data for Low Risk TAVR - (05:07)
Low risk TAVR study details, the patient impact, and safety insights at one year.
More information (see more)
Less information (see less)
Outreach and Education with Physicians and Patients - (05:10)
Relationships with referring physicians and why timely patient identification and referral is important.
More information (see more)
Less information (see less)
Key Topics around Low Risk Patients - (06:45)
Factors to consider when evaluating lifetime management of valvular heart disease.
More information (see more)
Less information (see less)
Pacemaker Considerations - (02:04)
Thoughts on pacemaker use after a TAVR procedure.
More information (see more)
Less information (see less)
Gradients and Selecting the Correct Valve Size - (05:29)
How hemodynamics, gradients, and annulus size play into valve size selection.
More information (see more)
Less information (see less)
Procedural Considerations - (02:25)
Thoughts on managing stroke risk and the benefits of conscious sedation.
More information (see more)
Less information (see less)
Hospital Economics - (02:53)
The impact and benefits of TAVR on hospital economics.
More information (see more)
Less information (see less)
What is Next for TAVR - (05:44)
Views on what may lie ahead for TAVR and valve durability.
More information (see more)
Less information (see less)
Question and Answer Segment with Physicians - (25:32)
Panelists address physicians’ hot topics and questions.
More information (see more)
Less information (see less)
CONNECT WITH US
Reach out to lifeline cardiovascular tech support with questions.
SYMPTOMATIC SEVERE AS CAN'T WAIT
Learn why an early referral to the heart team can make a lifesaving difference.
LEARN MORE